Alzheimer’s slowdown drugs unveiled

Drugs that could be the "first" to slow the progression of Alzheimer's disease have been unveiled by British researchers.

Results suggest that if given to patients early enough, the antibody therapies using solanezumab and aducanumab will be able to slow cognitive decline.

Interim results from a safety study of aducanumab in people with very early stage Alzheimer's disease, show the